What Researchers Did
Researchers retrospectively reviewed 67 necrotizing fasciitis cases to compare outcomes between patients who received adjuvant hyperbaric oxygen therapy and those who did not.
What They Found
The study found no significant difference in average length of hospital stay or mortality between the 29 HBO2 and 38 non-HBO2 groups. However, six (25%) patients in the non-HBO2 group required amputation of extremities compared to one patient in the HBO2 group. While not statistically significant (p=0.09), this suggests a potential trend for HBO2 to reduce amputations.
What This Means for Canadian Patients
For Canadian patients with necrotizing fasciitis, this study suggests hyperbaric oxygen therapy might potentially reduce the need for amputations, although the evidence is not statistically significant. Patients should discuss all treatment options, including HBO2, with their healthcare providers, recognizing that further research is needed to confirm these findings.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada or with Canadian participants.
Study Limitations
Key limitations include the retrospective design, small sample size, and the lack of statistical significance for the observed outcomes.